COVID-19 vaccines: neutralizing antibodies and the alum advantage.

Hotez, Peter J; Corry, David B; Strych, Ulrich; Bottazzi, Maria Elena

Hotez, Peter J; Corry, David B; Strych, Ulrich; Bottazzi, Maria Elena.

Hotez PJ; Texas Children's Center for Vaccine Development, Houston, TX, USA. hotez@bcm.edu.
Corry DB; Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA. hotez@bcm.edu.
Strych U; Department of Biology, Baylor University, Waco, TX, USA. hotez@bcm.edu.
Bottazzi ME; Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA. hotez@bcm.edu.

Nat Rev Immunol ; 20(7): 399-400, 2020 07.

Article in English | MEDLINE | ID: covidwho-536823

Subject(s)

Viral Vaccines/immunology; Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; COVID-19 Vaccines; Coronavirus Infections/immunology; Coronavirus Infections/prevention & control; Humans; Macaca mulatta; Mice; Viral Vaccines/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines Topics: Vaccines Limits: Animals / Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-0358-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google